126 related articles for article (PubMed ID: 5013242)
1. Development of large-scale fractionation methods. II. Isolation of a factor IX concentrate (prothrombin complex) for clinical use.
Wickerhauser M; Sgouris JT
Vox Sang; 1972; 22(2):137-60. PubMed ID: 5013242
[No Abstract] [Full Text] [Related]
2. The separation of clotting factors II (prothrombin) and IX (plasma thromboplastin component) by isoelectric focusing.
Pechet L; Smith JA
Biochim Biophys Acta; 1970 Mar; 200(3):475-85. PubMed ID: 4985341
[No Abstract] [Full Text] [Related]
3. The preparation of the factors IX, II, and X concentrate by means of DEAE cellulos and its therapeutic effectiveness.
Uszyński L; Poszwiński P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(5):591-4. PubMed ID: 54310
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in hemophilia. Part III. Discussion paper: The Red Cross program.
Greenwalt TJ
Ann N Y Acad Sci; 1975 Jan; 240():208-12. PubMed ID: 1053865
[No Abstract] [Full Text] [Related]
5. The separation of clotting factors. II. Purification of human factor IX by isoelectric focusing.
Chandra S; Pechet L
Biochim Biophys Acta; 1973 Dec; 328(2):456-63. PubMed ID: 4776454
[No Abstract] [Full Text] [Related]
6. A therapeutic concentrate of coagulation factors II, IX and X from citrated, factor VIII-depleted plasma.
Middleton SM; Bennett IH; Smith JK
Vox Sang; 1973 May; 24(5):441-56. PubMed ID: 4691239
[No Abstract] [Full Text] [Related]
7. Purification of human factor IX by chromatography of a coagulation factor concentrate.
Suomela H
Thromb Haemost; 1976 Feb; 35(1):211-21. PubMed ID: 989188
[TBL] [Abstract][Full Text] [Related]
8. Improved procedures for the purification of selected vitamin K-dependent proteins.
Novoa E; Seegers WH; Hassouna HI
Prep Biochem; 1976; 6(5):307-38. PubMed ID: 787972
[TBL] [Abstract][Full Text] [Related]
9. The preparation and clinical use of a new concentrate containing factor IX, prothrombin and factor X and of a separate concentrate containing factor VII.
Dike GW; Bidwell E; Rizza CR
Br J Haematol; 1972 Apr; 22(4):469-90. PubMed ID: 4112845
[No Abstract] [Full Text] [Related]
10. The isolation of prothrombin, Factor IX and Factor X from human Factor IX concentrates.
Modi GJ; Blajchman MA; Ofosu FA
Thromb Res; 1984 Dec; 36(6):537-47. PubMed ID: 6084874
[TBL] [Abstract][Full Text] [Related]
11. The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X.
Miletich JP; Broze GJ; Majerus PW
Anal Biochem; 1980 Jul; 105(2):304-10. PubMed ID: 6161558
[No Abstract] [Full Text] [Related]
12. Rapid purification of factor IX, factor X and prothrombin by immunoaffinity and ion exchange chromatography.
Ahmad SS; Rawala-Sheikh R; Thompson AR; Walsh PN
Thromb Res; 1989 Jul; 55(1):121-33. PubMed ID: 2781515
[TBL] [Abstract][Full Text] [Related]
13. Isolation of prekallikrein activator from guinea pig serum or plasma adsorbed to immune precipitates or celite: possible relationship to Hageman factor.
Treloar MP; Pyle H; Ozge-Anwar AH; Takeuchi Y; Movat HZ
Eur J Immunol; 1972 Aug; 2(4):338-45. PubMed ID: 5083514
[No Abstract] [Full Text] [Related]
14. Large-scale production and properties of a solvent-detergent-treated factor IX concentrate from human plasma.
Michalski C; Bal F; Burnouf T; Goudemand M
Vox Sang; 1988; 55(4):202-10. PubMed ID: 3265237
[TBL] [Abstract][Full Text] [Related]
15. Separation of blood coagulation factors II, VII, IX and X by gel filtration in the presence of dextran blue.
Swart AC; Hemker HC
Biochim Biophys Acta; 1970 Dec; 222(3):692-5. PubMed ID: 5496498
[No Abstract] [Full Text] [Related]
16. Affinity chromatography of coagulation factors II, VIII, IX and X on matrix-bound phospholipid vesicles.
Andersson LO; Thuy LP; Brown JE
Thromb Res; 1981 Sep; 23(6):481-9. PubMed ID: 6798706
[No Abstract] [Full Text] [Related]
17. Contributions to the optimal use of human blood. II. The large-scale preparation of prothrombin complex. A comparison between two methods using the anion exchangers DEAE-cellulose DE 52 and DEAE-sephadex A-50.
Heystek J; Brummelhuis HG; Krunen HW
Vox Sang; 1973; 25(2):113-23. PubMed ID: 4198999
[No Abstract] [Full Text] [Related]
18. Isolation and some properties of thrombin-E and other prothrombin derivatives.
Seegers WH; Walz DA; Reuterby J; McCoy LE
Thromb Res; 1974 Jun; 4(6):829-60. PubMed ID: 4858455
[No Abstract] [Full Text] [Related]
19. Prothrombal: a new concentrate of human prothrombin complex for clinical use.
Bruning PF; Loeliger EA
Br J Haematol; 1971 Oct; 21(4):377-98. PubMed ID: 5001176
[No Abstract] [Full Text] [Related]
20. The purification of human factor II (prothrombin) and the preparation of a specific antiserum.
Heystek J; Maier van den Zande GM; Brummelhuis HG; Krijnen HW
Vox Sang; 1974; 27(3):214-26. PubMed ID: 4213473
[No Abstract] [Full Text] [Related]
[Next] [New Search]
